ALBIREO PHARMA INC (ALBO)

US01345P1066 - Common Stock

44.15  -0.1 (-0.23%)

After market: 44.33 +0.18 (+0.41%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
57.39M40.58M8.31M9.64M12.74M
Cost Of Goods
2.55M1.36MN/AN/AN/A
Gross Profit
54.84M39.22MN/AN/AN/A
Operating Expenses
177.76M162.71M104.58M70.75M50.63M
Research and Development
88.70M82.52M76.78M45.58M31.73M
Selling, General, and Administrative Expenses
78.76M69.57M42.45M22.96M18.06M
Operating Income
-122.91M-123.48M-96.27M-61.11M-37.89M
Interest Income/Expense
-11.41M-13.93M-11.36M-5.30M-4.84M
Other Income/Expense
N/A103.39M0.003.69M-3.36M
Income Before Taxes
-134.93M-34.03M-107.63M-62.72M-46.09M
Income Tax
N/AN/AN/A0.0020.00K
Net Income
-131.15M-34.03M-107.63M-62.72M-46.11M
EBITDA
-122.48M-123.21M-96.08M-60.98M-37.84M
 
Per Share Data
EPS Diluted Total Ops
-6.72-1.77-6.73-5.04-3.94
Non GAAP EPS
-6.72-6.78-6.87-5.35-3.88
 
Statistics
Gross Profit Margin
95.56%96.66%N/AN/AN/A
Profit Margin
-228.51%-83.86%-1295.19%-650.62%-361.93%
Operating Profit Margin
-214.17%-304.31%-1158.48%-633.92%-297.41%

All data in USD

Charts